The medicine market is always fiercely competitive. To survive and affirm a position and trademark requires great efforts from domestic enterprises. PHARIMEXCO is regarded as one of the most successful enterprises and receives high appreciation from the social community for its investment in reshuffling production and business as well as its esteem for human health to manufacture the best drugs.
During its over 30-year history, Cuu Long Pharmaceutical Joint Stock Corp. (PHARIMEXCO) changed its names many times and officially transformed into a joint stock company in January 2005. In the last five years, the corporation has made great breakthroughs by investing in new technologies to manufacture high quality products. Its factories are furnished with modern technologies and equipment can produce 130 types of drugs of international standards such as antibiotics, febrifuges, palliatives, antiphlogistics, tonics, digestive drugs, medicines for liver and gall, cataplasm and eye drops.
The Vicancap factory is the unique in Vietnam to make gelatin capsules under the Canadian technology. The factory turns out 2 billion capsules a year, meeting the demand of domestic drug factories and for export. The firm is setting up plans for the construction of another factory to double its capacity to 4 billion capsules year by 2007. The South Korean technology-equipped Vikimco specialises in single-use syringes, transfusion sets and butterfly wing sets for social disease prevention centres. This facility produces more than 100 million units a year. General Director Luong Van Hoa said all three factories meet GMP and GLP standards and their storages also meet GSP standards. Therefore, PHARIMEXCO is one of a few pharmaceutical companies in Vietnam meeting all three standards. In addition, the corporation always guarantees an environment-friendly production and drainage. To improve quality and diversify product, the firm also set up the research and development (R&D) division. Hence, in 2005, PHARIMEXCO has 40 new products on the market, raising its pharmaceutical market share.
Not only an international standard manufacturer, PHARIMEXCO is also an dynamic flexible trader. The firm carries out all business and production activities via its marketing network and applies various sales promotion programmes as well as attractive after-sales policies. The corporation applies a specific programme for each new product. PHARIMEXCO classifies customer groups to apply suitable sales policies. It is even based on seasons and geographic locations to orient production and distribution for the best results. To date, the company has 17 branches and 500 outlets nationwide, capable of meeting all the market demand. It always heeds customers’ feedbacks to adjust its development strategies timely and soundly. Thanks to synchronous construction investment, development and orientation policies and especially customer policies, the company enjoys an annual growth of 20-30 per cent, contributing to the development of the Vietnamese pharmacy.
Under the pharmaceutical industry development plan until 2010, all drug facilities must satisfy GMP-WHO standards and the expenditure on drugs is from US$12-15 per person/year. Hence, the development potential is still huge. Hoa said, with the current background, PHARIMEXCO will continue reinforcing and developing to maintain its leadership in the domestic pharmacy and become a popular trademark. Accordingly, the firm will pour money into studying new products, complete the upgrading of its factories to meet GMP – WHO standards in August 2006, build the B-lactam factory, expand Vikimco and Vicancap factories and widen the market, especially export market. Additionally, the firm organises emulation and creativity campaigns to increase productivity and economise its production, which also helps improve the incomes of its staff.
Hoang Lam
Vietnamese
